The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016
Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013
Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Exhaled breath condensate (EBC): what is sampled and how should it be collected? (recommendations and open issues) Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate Year: 2007
Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010
8-isoprostane in breath condensate in patients with exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005
Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018
Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003
pH in exhaled breath condensate of patients with stable COPD: associations with disease severity and pulmonary function tests Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009
Detection and characterisation of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients Source: Eur Respir J, 58 (2) 2003024; 10.1183/13993003.03024-2020 Year: 2021
Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006
Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005
Nitrite/nitrate in exhaled breath condensate (EBC) of patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006
Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008
Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes. Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017
Relationship of inflamamatory markers in blood and exhaled breath condensate in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006
Dynamics of exhaled breath temperature (EBT) after a smoked cigarette Source: International Congress 2016 – New approaches and finding in smoking cessation Year: 2016